Literature DB >> 8657831

Haloperidol differentially affects reinforcement and motivational processes in rats running an alley for intravenous heroin.

K McFarland1, A Ettenberg.   

Abstract

The role of drug-paired environmental stimuli in opiate self-administration was investigated by exposing animals to discrete cues that were predictive of the availability or unavailability of heroin reinforcement. Rats were trained to traverse a straight arm runway for a reinforcement consisting of a single 0.1 mg/kg intravenous infusion of heroin delivered upon entrance to the goal box. On each trial, one of two discriminative olfactory stimuli (orange and almond) was used: one which signaled the availability of heroin in the goal box (S+), and one which signaled its absence (S-). The effect of dopamine (DA) receptor antagonism on reinforcement and motivational processes was investigated by pretreating subjects with 0.0, 0.15 or 0.30 mg/kg of the DA receptor antagonist drug, haloperidol. Haloperidol had no effect on operant runway performance (i.e. goal time) in any condition. However, 24 h later, on the first post-treatment trial, those haloperidol animals that received heroin in the goal box on the previous trial (i.e. the S+ condition) ran reliably more slowly than subjects that received vehicle on the previous S+ trial. These results suggest that haloperidol does not affect the motivational properties of stimuli which predict the availability of heroin, while it does diminish the reinforcing effects of actually receiving heroin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8657831     DOI: 10.1007/bf02246264

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  Conditioned narcotic withdrawal in humans.

Authors:  C P O'Brien; T Testa; T J O'Brien; J P Brady; B Wells
Journal:  Science       Date:  1977-03-11       Impact factor: 47.728

2.  Catecholamines and self-stimulation: reward and performances effects dissociated.

Authors:  K B Franklin
Journal:  Pharmacol Biochem Behav       Date:  1978-12       Impact factor: 3.533

3.  Does pimozide block the reinforcing effect of brain stimulation?

Authors:  C R Gallistel; M Boytim; Y Gomita; L Klebanoff
Journal:  Pharmacol Biochem Behav       Date:  1982-10       Impact factor: 3.533

4.  Effects of haloperidol in a response-reinstatement model of heroin relapse.

Authors:  A Ettenberg; L A MacConell; T D Geist
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

5.  Susceptibility to readdiction as a function of the addiction and withdrawal environments.

Authors:  T Thompson; W Ostlund
Journal:  J Comp Physiol Psychol       Date:  1965-12

6.  Narcotic use in southeast Asia and afterward. An interview study of 898 Vietnam returnees.

Authors:  L N Robins; J E Helzer; D H Davis
Journal:  Arch Gen Psychiatry       Date:  1975-08

7.  Pimozide-induced extinction in rats: stimulus control of responding rules out motor deficit.

Authors:  K B Franklin; S N McCoy
Journal:  Pharmacol Biochem Behav       Date:  1979-07       Impact factor: 3.533

8.  Conditioned incentive properties of a food-paired conditioned stimulus remain intact during dopamine receptor blockade.

Authors:  J C Horvitz; A Ettenberg
Journal:  Behav Neurosci       Date:  1991-08       Impact factor: 1.912

9.  Pavlovian conditioning and addictive behavior: relapse to oral self-administration of morphine.

Authors:  R E Hinson; C X Poulos; W Thomas; H Cappell
Journal:  Behav Neurosci       Date:  1986-06       Impact factor: 1.912

10.  Pimozide blocks establishment but not expression of cocaine-produced environment-specific conditioning.

Authors:  R J Beninger; R S Herz
Journal:  Life Sci       Date:  1986-04-14       Impact factor: 5.037

View more
  16 in total

Review 1.  Forebrain substrates of reward and motivation.

Authors:  Roy A Wise
Journal:  J Comp Neurol       Date:  2005-12-05       Impact factor: 3.215

2.  Morphine-conditioned single-trial place preference: role of nucleus accumbens shell dopamine receptors in acquisition, but not expression.

Authors:  Sandro Fenu; Liliana Spina; Emilia Rivas; Rosanna Longoni; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2006-05-25       Impact factor: 4.530

3.  Drug-motivated behavior in rats with lesions of the thalamic orosensory area.

Authors:  Jennifer E Nyland; Danielle N Alexander; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2015-12-14       Impact factor: 1.912

4.  Restriction of dopamine signaling to the dorsolateral striatum is sufficient for many cognitive behaviors.

Authors:  Martin Darvas; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

5.  Nicotine-conditioned single-trial place preference: selective role of nucleus accumbens shell dopamine D1 receptors in acquisition.

Authors:  Liliana Spina; Sandro Fenu; Rosanna Longoni; Emilia Rivas; Gaetano Di Chiara
Journal:  Psychopharmacology (Berl)       Date:  2005-12-10       Impact factor: 4.530

6.  Effects of haloperidol in a response-reinstatement model of heroin relapse.

Authors:  A Ettenberg; L A MacConell; T D Geist
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

7.  Modeling operant behavior in the Parkinsonian rat.

Authors:  Irene Avila; Mark P Reilly; Federico Sanabria; Diana Posadas-Sánchez; Claudia L Chavez; Nikhil Banerjee; Peter Killeen; Eddie Castañeda
Journal:  Behav Brain Res       Date:  2008-11-27       Impact factor: 3.332

Review 8.  Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex.

Authors:  Satoshi Ikemoto
Journal:  Brain Res Rev       Date:  2007-05-17

Review 9.  Dopamine and reward: the anhedonia hypothesis 30 years on.

Authors:  Roy A Wise
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

10.  Restricting dopaminergic signaling to either dorsolateral or medial striatum facilitates cognition.

Authors:  Martin Darvas; Richard D Palmiter
Journal:  J Neurosci       Date:  2010-01-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.